Health

HSA Approves Pfizer Covid-19 Tablet For Patients At Higher Risk Of Severe Illness

HSA Announces ‘Interim Authorisation’ Of Pfizer Tablet On 3 Feb

Singapore has approved its first oral tablet for Covid-19, more than 2 years after the pandemic started.

On Thursday (3 Feb), the Health Sciences Authority (HSA) announced that they had granted approval for Pfizer’s PAXLOVID tablet.

Source

The pill will be used to treat patients with mild symptoms but who are at high risk of developing severe infections and even death.

HSA approves Pfizer tablet for Covid-19

According to HSA, PAXLOVID was given “interim authorisation” on 31 Jan under the Pandemic Special Access Route (PSAR).

The tablet comprises 2 drugs—nirmatrelvir and ritonavir. The former is the antiviral medicine, while the latter ensures the blood level of nirmatrelvir for “antiviral efficacy”.

PAXLOVID will be used to treat adult Covid-19 patients with mild symptoms but have a high risk of worsening conditions.

Patients prescribed with PAXLOVID are to take the tablet twice per day for a period of 5 days.

Tablets reduce hospitalisation & death rates among Covid-19 patients

After reviewing available clinical data, HSA found that PAXLOVID significantly reduces the risk of hospitalisation or death.

In particular, the drug was found to reduce the number by 88.9% and 87.8% when given within 3 and 5 days from the onset of symptoms.

 

Lab results have also shown that PAXLOVID is “active against” infectious variants like the Delta and Omicron strains.

The side effects of consuming the tablet were described as being “generally low”. These include:

  • altered sense of taste
  • chills
  • diarrhoea
  • hypertension
  • muscle pain
  • vomiting.

Doctors are also advised to consider drug interactions before prescribing PAXLOVID as it could increase or decrease the levels of certain drugs in patients’ blood.

Nonetheless, HSA said the benefits of PAXLOVID outweigh its risks, especially for Covid-19 patients who are at high risk of suffering from severe illness.

Hope drug will reduce load in hospitals

Despite the countless medical breakthrough we’ve made to deal with Covid-19, the pandemic continues to disrupt lives around the world.

We hope PAXLOVID will prove effective in preventing Covid-19 patients from falling severely ill, and in turn, helping to reduce the load in our hospitals.

Have news you must share? Get in touch with us via email at news@mustsharenews.com.

Featured image adapted from get to text

The Must Share News Team

Teamwork makes the dream work.

Recent Posts

Passenger on US flight slammed for bringing Great Dane as ’emotional support’ dog

On the other hand, some said they'd prefer sitting next to a massive dog than…

23 Dec 2024, 10:12 am

Nearly 20 cats abandoned in Bedok flat filled with rubbish, some injured after jumping from windows

Some sustained injuries after jumping from windows, while others starved to death.

23 Dec 2024, 9:52 am

Continuous heavy traffic expected at S’pore-JB checkpoints till end of 2024: ICA

A record of more than 553,000 travellers crossed both checkpoints on 13 Dec.

22 Dec 2024, 7:25 pm

H5N1 poses ‘highest risk’ of becoming next pandemic, S’pore health authorities monitoring situation

There has been no year-end Covid-19 wave, as had been expected.

22 Dec 2024, 6:42 pm

Wagyu beef worth S$5,700 found in car entering JB from S’pore, M’sian driver arrested

The beef was imported without a veterinary health certificate and halal certification.

22 Dec 2024, 5:40 pm

Long queue forms at Jalan Besar Stadium for tickets to ASEAN Championship semi-final

One fan started queueing as early as 7am.

22 Dec 2024, 4:50 pm